ARGENT BIOPHARMA LTD ORDINARY (RGT) Short Interest
ARGENT BIOPHARMA LTD ORDINARY (ASX:RGT) had 0.00% of shares reported as short positions as of 14 July 2026, representing 1 shares. ARGENT BIOPHARMA LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Unlock advanced features: Custom dashboards, portfolio tracking, real-time alerts, and more
Argent Biopharma
Argent Biopharma Limited is a European-based pharmaceuticals company that focuses on creating innovative plant-inspired medicines and treatments addressing unmet medical conditions. The firm leverages its unique expertise in extracting and processing natural compounds to produce pharmaceuticals that serve niche, underserved markets. With a strong research and development emphasis, Argent positions itself as a leader in naturally-derived pharmaceutical solutions, aiming to enhance treatment efficacy and patient safety.